Detalhe da pesquisa
1.
Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel.
PLoS One
; 17(1): e0261775, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051209
2.
Development of a Vaginal Fast-Dissolving Insert Combining Griffithsin and Carrageenan for Potential Use Against Sexually Transmitted Infections.
J Pharm Sci
; 107(10): 2601-2610, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29902477
3.
Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo.
Nat Commun
; 9(1): 3881, 2018 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30250170
4.
An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques.
Drug Deliv Transl Res
; 7(6): 840-858, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600625
5.
A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
J Control Release
; 213: 57-68, 2015 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26091920